Perimenopause remains one of the most clinically under-served transitions in women's health, and a major reason may be that millions of women cannot identify when they're in it. Understanding why this recognition gap exists — and who it hits hardest — has real implications for timely hormonal evaluation, symptom management, and long-term cardiovascular and bone health outcomes tied to estrogen decline.
A large cross-sectional survey of 7,640 US women aged 35 and above, published in Menopause, found that 34% of participants were unsure of their reproductive stage. Uncertainty peaked at 42% among women aged 40–44, a window that overlaps heavily with early perimenopause onset. Among those with severe symptom burden, uncertainty remained elevated at 37%, underscoring a counterintuitive pattern: even symptomatic women often cannot connect their experiences to hormonal transition. Qualitative content analysis of 409 free-text responses identified three structural drivers — symptom confusion and misattribution (56%), knowledge gaps and limited health literacy (28%), and healthcare access barriers including dismissive clinical encounters (16%). Younger women in the 35–39 bracket disproportionately cited knowledge gaps, while the 40–44 cohort reported the highest rates of healthcare dismissal.
This research sits within a growing literature documenting the systematic underdiagnosis of perimenopause, but its scale and mixed-methods design give it unusual analytical depth. The finding that symptom severity does not resolve uncertainty is particularly important: it challenges any assumption that women who are suffering will naturally self-identify and seek care. The healthcare dismissal theme also resonates with broader equity concerns — provider skepticism about perimenopausal symptoms in younger or pre-menopausal-appearing patients is well-documented anecdotally but rarely quantified this rigorously. Limitations include the cross-sectional design, which precludes causal inference, and potential self-selection bias in online surveys. Still, this study functions as a credible population-level signal that perimenopause literacy — both among patients and clinicians — represents a meaningful and addressable public health gap.
